146. Support Care Cancer. 2018 Jun;26(6):1687. doi: 10.1007/s00520-018-4113-5. Epub2018 Feb 21.Administrating docetaxel, doxorubicin, and cyclophosphamide as a neoadjuvanttreatment may decrease lymphedema risk in breast cancer patients.Altundag K(1).Author information: (1)MKA Breast Cancer Clinic, Tepe Prime, 06800, Ankara, Cankaya, Turkey.altundag66@yahoo.com.DOI: 10.1007/s00520-018-4113-5 PMID: 29468271 